Assessment of survival in patients with idiopathic pulmonary fibrosis using quantitative HRCT indexes

被引:23
作者
Torrisi, Sebastiano Emanuele [1 ]
Palmucci, Stefano [2 ]
Stefano, Alessandro [3 ]
Russo, Giorgio [3 ]
Torcitto, Alfredo Gaetano [2 ]
Falsaperla, Daniele [2 ]
Gioe, Mauro [4 ]
Pavone, Mauro [1 ]
Vancheri, Ada [1 ]
Sambataro, Gianluca [1 ,5 ]
Sambataro, Domenico [5 ]
Mauro, Letizia Antonella [2 ]
Grassedonio, Emanuele [6 ]
Basile, Antonio [2 ]
Vancheri, Carlo [1 ]
机构
[1] Univ Catania, Reg Referral Ctr Rare Lung Dis, AOU Policlin Vittorio Emanuele, Dept Clin & Expt Med, Via Santa Sofia 78, Catania, Italy
[2] Univ Hosp Policlin Vittorio Emanuele, Dept Med Surg Sci & Adv Technol, Radiol Unit 1, Catania, Italy
[3] Inst Mol Bioimaging & Physiol, Contrada Pietropollastra Pisciotta, Natl Res Council IBFM CNR, I-90015 Cefalu, Italy
[4] Univ Pavia, Dept Brain & Behav Sci, Pavia, Italy
[5] Artroreuma Srl, Outpatient Rheumatol Accredited Natl Hlth Syst, Corso San Vito 53, I-95030 Mascalucia, CT, Italy
[6] Univ Palermo, Univ Hosp Paolo Giaccone, Sect Radiol Sci, DIBIMEF, Palermo, Italy
来源
MULTIDISCIPLINARY RESPIRATORY MEDICINE | 2018年 / 13卷
关键词
Idiopathic pulmonary fibrosis; HRCT; Kurtosis; Usual interstitial pneumonia; Survival; Mortality;
D O I
10.1186/s40248-018-0155-2
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
BackgroundThe assessment of Idiopathic Pulmonary Fibrosis (IPF) using HRCT requires great experience and is limited by a significant inter-observer variability, even between trained radiologists. The evaluation of HRCT through automated quantitative analysis may hopefully solve this problem. The accuracy of CT-histogram derived indexes in the assessment of survival in IPF patients has been poorly studied.MethodsForty-two patients with a diagnosis of IPF and a follow up time of 3years were retrospectively collected; HRCT and Pulmonary Function Tests (PFTs) performed at diagnosis time were analysed; the extent of fibrotic disease was quantified on HRCT using kurtosis, skewness, Mean Lung Density (MLD), High attenuation areas (HAA%) and Fibrotic Areas (FA%). Univariate Cox regression was performed to assess hazard ratios for the explored variables and a multivariate model considering skewness, FVC, DLCO and age was created to test their prognostic value in assessing survival. Through ROC analysis, threshold values demonstrating the best sensitivity and specificity in predicting mortality were identified. They were used as cut-off points to graph Kaplan-Meier curves specific for the CT-indexes.ResultsKurtosis, skewness, MLD, HAA% and FA% were good predictors of mortality (HR 0.44, 0.74, 1.01, 1.12, 1.06; p=0.03, p=0.01, p=0.02, p=0.02 and p=0.017 respectively). Skewness demonstrated the lowest Akaike's information criterion value (55.52), proving to be the best CT variable for prediction of mortality. Significant survival differences considering proposed cut-off points were also demonstrated according to kurtosis (p=0.02), skewness (p=0.005), MLD (p=0.003), HAA% (p=0.009) and FA% (p=0.02) - obtained from quantitative HRCT analysis at diagnosis time.ConclusionsCT-histogram derived indexes may provide an accurate estimation of survival in IPF patients. They demonstrate a correlation with PFTs, highlighting their possible use in clinical practice.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Prognostic Factors in Patients with Idiopathic Pulmonary Fibrosis; Evaluation using Quantitative CT analysis of Fibrosis and Emphysema
    Nakagawa, Hiroaki
    Fukunaga, Kentaro
    Ikeda, Satoshi
    Okuda, Ryo
    Kitamura, Hideya
    Baba, Tomohisa
    Nakano, Yasutaka
    Ogura, Takashi
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [32] A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis
    Nishiyama, O.
    Taniguchi, H.
    Kondoh, Y.
    Kimura, T.
    Kato, K.
    Kataoka, K.
    Ogawa, T.
    Watanabe, F.
    Arizono, S.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2010, 36 (05) : 1067 - 1072
  • [33] The effect of emphysema on survival in patients with idiopathic pulmonary fibrosis: A retrospective study in Taiwan
    Lai, Ruay-Sheng
    Chen, Chiu-Fan
    Chu, Kuo-An
    Lin, Min-Hsi
    [J]. JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2019, 82 (12) : 922 - 928
  • [34] Comorbidity burden and survival in patients with idiopathic pulmonary fibrosis: the EMPIRE registry study
    Dragana M. Jovanovic
    Martina Šterclová
    Nesrin Mogulkoc
    Katarzyna Lewandowska
    Veronika Müller
    Marta Hájková
    Michael Studnicka
    Jasna Tekavec-Trkanjec
    Simona Littnerová
    Martina Vašáková
    [J]. Respiratory Research, 23
  • [35] Comorbidity burden and survival in patients with idiopathic pulmonary fibrosis: the EMPIRE registry study
    Jovanovic, Dragana M.
    Sterclova, Martina
    Mogulkoc, Nesrin
    Lewandowska, Katarzyna
    Muller, Veronika
    Hajkova, Marta
    Studnicka, Michael
    Tekavec-Trkanjec, Jasna
    Littnerova, Simona
    Vasakova, Martina
    [J]. RESPIRATORY RESEARCH, 2022, 23 (01)
  • [36] SURFACTANT PROTEIN-D PREDICTS SURVIVAL IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
    Barlo, N. P.
    van Moorsel, C. H. M.
    Ruven, H. J. T.
    Zanen, P.
    van den Bosch, J. M. M.
    Grutters, J. C.
    [J]. SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2009, 26 (02) : 155 - 161
  • [37] Epidemiologic Analysis of Taiwanese Patients with Idiopathic Pulmonary Fibrosis
    Yang, Sheau-Ning
    Perng, Diahn-Warng
    Ko, Hsin-Kuo
    Chang, Yuh-Lih
    Hsu, Chia-Chen
    Huang, Hsin-Yi
    Chung, Mei-Ing
    [J]. HEALTHCARE, 2020, 8 (04)
  • [38] Staging of Acute Exacerbation in Patients with Idiopathic Pulmonary Fibrosis
    Kishaba, Tomoo
    Tamaki, Hitoshi
    Shimaoka, Yousuke
    Fukuyama, Hajime
    Yamashiro, Shin
    [J]. LUNG, 2014, 192 (01) : 141 - 149
  • [39] Blood Cell Count Derived Inflammation Indexes in Patients with Idiopathic Pulmonary Fibrosis
    Angelo Zinellu
    Panagiotis Paliogiannis
    Elisabetta Sotgiu
    Sabrina Mellino
    Arduino A. Mangoni
    Elisabetta Zinellu
    Silvia Negri
    Claudia Collu
    Gianfranco Pintus
    Antonello Serra
    Angelo Maria Pistuddi
    Ciriaco Carru
    Pietro Pirina
    Alessandro G. Fois
    [J]. Lung, 2020, 198 : 821 - 827
  • [40] Pharmacotherapy in patients with idiopathic pulmonary fibrosis
    Nagai, S.
    Handa, T.
    Kim, D. S.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (11) : 1909 - 1925